Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China flag China · Delayed Price · Currency is CNY
26.55
-0.48 (-1.78%)
Feb 11, 2026, 4:00 PM EST

SHA:688163 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
196.76194.92190.13174.21207.5185.45
Other Revenue
--0.020.011.190.11
196.76194.92190.14174.22208.69185.56
Revenue Growth (YoY)
-0.27%2.51%9.14%-16.52%12.46%-1.35%
Cost of Revenue
46.9145.849.8433.536.3335.3
Gross Profit
149.86149.11140.3140.72172.36150.27
Selling, General & Admin
75.9776.7174.3573.7162.8152.62
Research & Development
20.5523.8430.4115.4625.7622.52
Other Operating Expenses
5.451.681.531.211.45-3.25
Operating Expenses
102.97102.96107.0890.2890.3471.56
Operating Income
46.8946.1533.2250.4582.0378.71
Interest Expense
-0.2-0.43-0.65-0.68-0.71-
Interest & Investment Income
4.196.1210.6216.31.482.33
Currency Exchange Gain (Loss)
-0.03-0.030.120.49-0.12-
Other Non Operating Income (Expenses)
0.80.23-0.250.42-0.3-0.96
EBT Excluding Unusual Items
51.6452.0443.0666.9782.3880.09
Gain (Loss) on Sale of Investments
-5.17-4.972.592.62-0.79-5.34
Gain (Loss) on Sale of Assets
-1.030.41-0.01-0.07-0.25-
Asset Writedown
2.73-----
Other Unusual Items
3.593.09-0.234.536.54-
Pretax Income
51.7550.5745.4274.0487.8874.75
Income Tax Expense
6.26.286.649.8411.3911.58
Earnings From Continuing Operations
45.5544.2938.7764.276.4863.17
Net Income
45.5544.2938.7764.276.4863.17
Net Income to Common
45.5544.2938.7764.276.4863.17
Net Income Growth
-10.55%14.23%-39.60%-16.06%21.07%-3.93%
Shares Outstanding (Basic)
1081081081028181
Shares Outstanding (Diluted)
1081081081028181
Shares Change (YoY)
0.19%0.30%5.70%25.24%0.46%-0.23%
EPS (Basic)
0.420.410.360.630.940.78
EPS (Diluted)
0.420.410.360.630.940.78
EPS Growth
-10.72%13.89%-42.86%-32.98%20.51%-3.70%
Free Cash Flow
-27.92-9.124.1541.4664.6880.43
Free Cash Flow Per Share
-0.26-0.080.040.410.800.99
Dividend Per Share
0.3200.3200.2000.7500.900-
Dividend Growth
-60.00%-73.33%-16.67%--
Gross Margin
76.16%76.50%73.79%80.77%82.59%80.98%
Operating Margin
23.83%23.68%17.47%28.96%39.30%42.42%
Profit Margin
23.15%22.72%20.39%36.85%36.65%34.04%
Free Cash Flow Margin
-14.19%-4.68%2.18%23.79%30.99%43.34%
EBITDA
68.5865.549.4664.4396.15-
EBITDA Margin
34.85%33.61%26.01%36.98%46.07%-
D&A For EBITDA
21.6919.3616.2413.9814.12-
EBIT
46.8946.1533.2250.4582.0378.71
EBIT Margin
23.83%23.68%17.47%28.96%39.30%42.42%
Effective Tax Rate
11.98%12.41%14.62%13.29%12.97%15.49%
Revenue as Reported
196.76194.92190.14174.22208.69185.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.